You searched for "NAION"
Systemic pharmacology of intravitreal anti-VEGF
This study aimed to evaluate and compare serum drug concentrations and plasma free-VEGF concentrations in patients with AMD, DME, or RVO receiving intravitreal injections of aflibercept, bevacizumab or ranibizumab. This prospective study enrolled patients from several offices of a single...
Prognostic information for PRP-naive patients
The Diabetic Retinopathy Study group demonstrated that pan retinal laser photocoagulation (PRP) reduces severe vision loss by up to 50% in cases of proliferative diabetic retinopathy (PDR). The authors of this current study aimed to provide information for laser naive...
Inhibiting high-risk corneal allografts
The cornea is an immune privileged site and as such corneal transplants are very successful. However, in situations where this privilege is lost the failure rises substantially. To combat rejection inhibition of the immune responses depends on steroids and other...
Macular atrophy with aflibercept
The authors of this paper set out to investigate the prevalence of macular atrophy in treatment-naive patients with neovascular AMD undergoing aflibercept monotherapy (three monthly loading injections followed by subsequent treatment every two months). Case notes over a three year...I am interested in making my ophthalmology practice sustainable, but where do I start?
I have yet to meet an ophthalmologist who does not care about a sustainable future for our planet, but the challenge lies in knowing where and how to start. Quite often, as individuals, we see ourselves less empowered when it...RNIB CEO to step down in December 2025
Matt Stringer, Chief Executive of the Royal National Institute of Blind People (RNIB) has announced that he will be stepping down from his role. Matt has led RNIB through some challenging times such as the statutory inquiry, the Covid-19 pandemic...Sense Medical and Canon: Getting ready for the OCT Pathway in Diabetic Eye Screening Surveillance Pathway webinar
Are you ready for the OCT pathway in DESP? OCT is set to be integrated into the English National Diabetic Eye Screening Surveillance Pathway, significantly enhancing the management of patients with mild diabetic maculopathy. This advancement allows patients to remain within a surveillance pathway overseen by retinal screening rather than being immediately referred to the Hospital Eye Service (HES). The webinar will be hosted by Professor Tunde Peto and Mrs Samantha Mann and will discuss the new OCT pathway, how OCT will change diabetic screening, how to interpret OCT images and how programmes can get ready for the change. Starts at 6pm UK time for 90 minutesOSA chair passes to a delighted James Conway
Longstanding OSA Director James Conway is delighted to have been appointed as the new OSA Chair, following the retirement of Roy Stoner after a three-year tenure. The OSA’s AGM and Christmas lunch at the Bloomsbury Hotel, London, saw Roy pass...Webinar will look at impact of menopause on eye health
A BCLA webinar will look at the impact going through the menopause can have on female eye health.Haag-Streit announces winners of Slit Lamp Imaging Competition 2023
Haag Streit is pleased to announce the release of the results of its Slit Lamp Imaging Competition 2023.BARS (British Association of Retinal Screening) Conference 2023
Why not join us at the BARS Conference 2023 in the vibrant city of Bristol, at the Marriott Hotel on Thursday 28 and Friday 29 September. This year there is something for everyone with an interest in diabetic eye screening....
